ARCHIVES

In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman

This article is from The Cancer Letter archive.

Vol. 14 No. 36 | September 2, 1988

Download PDF Visit The Full Archive

Related Articles

EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation

May 30, 2014

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

NIH Reconsiders Closing A Meeting Of Advisory Group

January 13, 1995

Cancer Care Act Introduced In Senate.

April 18, 2008

Patient Advocacy: Committee To Advise NCI On Formation Of Liaison Group

February 28, 1997

Kerrie Wilson Succeeds Alan Davis As ACS Chief Lobbyist

November 26, 1993